Immunosuppression

Immunosuppression therapy helps the body to not reject its new organ. Dramatic advances in immunosuppression, and various aspects of patient management have made transplantation a more viable treatment for end-stage organ failure.

Following transplantation surgery, anti-rejection or immunosuppression drugs begin immediately, and must be taken for the rest of the patient’s life.

The transplant physician will determine which combination of drugs is appropriate for each individual patient. Generally, three or four types are prescribed. Following is a list of the most commonly used immunosuppression medications:

Sandimmune® (cyclosporine, USP)
Neoral® (cyclosporine, USP) MODIFIED
Simulect® (basiliximab)
Gengraf®
Imuran® (azathioprine)
Prograf® (tacrolimus)
Rapamune® (sirolimus)
Zenapax® (daclizumab)
Steroids (prednisone)
ATGA

Related Links:

www.unos.org